Nutex Health (NUTX) Cash from Financing Activities (2012 - 2026)

Nutex Health has reported Cash from Financing Activities for 14 years, with the latest figure at -$49.5 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 627.38% year-over-year to -$49.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$140.7 million (down 1133.33% YoY) and the FY2025 annual result came in at -$97.9 million, down 9077.91% from the prior year.
• Cash from Financing Activities slipped to -$49.5 million in Q1 2026 per NUTX's latest filing, from -$45.8 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $5.7 million in Q1 2024 and troughed at -$49.5 million in Q1 2026.
• A 5-year average of -$11.6 million and a median of -$4.3 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities tumbled 7144.95% in 2022, then jumped 137.74% in 2023.
• Over 5 years, Cash from Financing Activities stood at -$14.8 million in 2022, then soared by 73.47% to -$3.9 million in 2023, then climbed by 23.72% to -$3.0 million in 2024, then slumped by 1433.52% to -$45.8 million in 2025, then declined by 8.21% to -$49.5 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered -$49.5 million, -$45.8 million, and -$29.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.